Follow
Multiple Myeloma
Multiple Myeloma: is a cancer that forms in certain types of white blood cells called plasma cells. Plasma cells help you fight off infections by creating and making antibodies that recognize and attack germs in the body. Multiple myeloma causes cancer cells to grow in the bone marrow, where they eventually push out the healthy cells. The cancer cells produce abnormal proteins that can cause complications.
What's Popular in Multiple Myeloma
-
MAR 06, 2024Health & Medicine
Gone are the days when therapies for medical conditions were based solely on statistical data of the broad population, l ...Sponsored By: ESSERT RoboticsJUL 17, 2023Drug Discovery & DevelopmentIntroduction Antibodies are the ideal therapeutic biomolecules due to their ability to bind to a variety of targets with ...MAR 29, 2023Clinical & Molecular DX
A new review paper, which takes a broad view of research developments in a field, has suggested that the circadian rhyth ...Written By: Carmen LeitchJAN 17, 2023Clinical & Molecular DX
When it comes to detecting rare cancer-causing mutations, both sensitivity and specificity matter. In the past few years ...Sponsored By: Roche Sequencing and Life ScienceDEC 30, 2022Cancer
As we near the end of 2022, and enter our fourth year of facing COVID-19 (so named because of it’s emergence in 20 ...Written By: Katie Kokolus
MAR 06, 2024
Health & Medicine
Gone are the days when therapies for medical conditions were based solely on statistical data of the broad population, l
...
Sponsored By:
ESSERT Robotics
JUL 17, 2023
Drug Discovery & Development
Introduction Antibodies are the ideal therapeutic biomolecules due to their ability to bind to a variety of targets with
...
MAR 29, 2023
Clinical & Molecular DX
A new review paper, which takes a broad view of research developments in a field, has suggested that the circadian rhyth
...
Written By:
Carmen Leitch
JAN 17, 2023
Clinical & Molecular DX
When it comes to detecting rare cancer-causing mutations, both sensitivity and specificity matter. In the past few years
...
Sponsored By:
Roche Sequencing and Life Science
DEC 30, 2022
Cancer
As we near the end of 2022, and enter our fourth year of facing COVID-19 (so named because of it’s emergence in 20
...
Written By:
Katie Kokolus
DEC 26, 2022
Immunology
Almost every patient who gets myeloma and is treated with a standard therapy also experiences relapse. But researchers h
...
Written By:
Carmen Leitch
SEP 13, 2022
Cancer
Introduction Cancer is the second leading cause of death globally. According to estimates from the American Cancer Socie
...
Sponsored By:
Sino Biological
JUL 11, 2022
Cancer
Chimeric antigen receptor (CAR) T Cell therapy has emerged as a promising immunotherapeutic approach to treat blood canc
...
Written By:
Katie Kokolus
JAN 20, 2022
Immunology
Scientists studying a neglected tropical disease have made a chance discovery—a promising therapeutic targe
...
Written By:
Tara Fernandes
-
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...SEP 26, 2023 | 11:00 AM
Multicolor flow cytometry is beneficial because it allows us to gain deeper insights from a given biological sample, with fewer repeat markers in each tube and quicker results. In this three...AUG 01, 2023 | 9:00 AM
Testing for abnormal immunoglobulins was based previously on serum electrophoresis and immunofixation only. In the last years, however, free light chain (FLC) testing in serum became one imp...MAY 25, 2023 | 10:00 AM
Free light chains, kappa (κ) lambda (λ), are produced by plasma cells and known to be an important marker in patients with Multiple Myeloma and AL Amyloidosis. The precursor con...JUN 21, 2022 | 11:00 AM
Date: June 21, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Multiple myeloma is a cancer of the plasma cell. Plasma cells are white blood cells that make antibodies that help to pro...
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
SEP 26, 2023 | 11:00 AM
Multicolor flow cytometry is beneficial because it allows us to gain deeper insights from a given biological sample, with fewer repeat markers in each tube and quicker results. In this three...
AUG 01, 2023 | 9:00 AM
Testing for abnormal immunoglobulins was based previously on serum electrophoresis and immunofixation only. In the last years, however, free light chain (FLC) testing in serum became one imp...
MAY 25, 2023 | 10:00 AM
Free light chains, kappa (κ) lambda (λ), are produced by plasma cells and known to be an important marker in patients with Multiple Myeloma and AL Amyloidosis. The precursor con...
JUN 21, 2022 | 11:00 AM
Date: June 21, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Multiple myeloma is a cancer of the plasma cell. Plasma cells are white blood cells that make antibodies that help to pro...
NOV 30, 2021 | 11:00 AM
Date: November 30, 2021 Time: 11:00am (PDT), 2:00pm (EDT) In the recent years, measurable residual disease (MRD) assessment on multiple myeloma patients has gained increasing relevance. After...
JUN 29, 2021 | 9:00 AM
Date: June 29, 2021 Time: 9:00am (PDT), 12:00pm (EDT) This month’s LabRoots discussion titled “Laboratory Screening for Multiple Myeloma: A Nudge in the Direction of Guideline Co...
APR 20, 2021 | 12:00 AM
Learning Objectives: 1. Learn about alternative promoters and their role in cancer 2. Learn how long read RNA-Seq helps to study the transcriptome...
MAR 23, 2021 | 9:00 AM
Date: March 23, 2021 Time: 9:00am (PST), 12:00pm (EST) The chromatin regulators CBP and p300 maintain gene expression programs through lysine acetylation of chromatin and transcriptional reg...
-
10/14-15 9am-1pm CDT
Coming to you from a safe, physical distance, 2020 Abbott World Summit. This event will feature over 15 global experts sharing their latest discoveries and experiences in cancer screening, r...10/13-14 from 1-5pm SGT
Coming to you from a safe, physical distance, Abbott 2020 world oncology summit. Covering diverse and timely topics in cancer education, from updates in cancer emerging new diagnostics resea...OCT 11, 2017 | 6:00 AM PDT
The 5th Annual Event in the Cancer Research & Oncology Week Virtual Event Series is now On-Demand!...OCT 05, 2016 | 6:00 AM PDT
The 4th Annual Event in the Cancer Research & Oncology Week Virtual Event Series is now On Demand! This premier cancer research conference makes it easier and more cost-effective for the...SEP 30, 2015 | 6:00 AM PDT
Welcome to Labroots 3rd Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...
10/14-15 9am-1pm CDT
Coming to you from a safe, physical distance, 2020 Abbott World Summit. This event will feature over 15 global experts sharing their latest discoveries and experiences in cancer screening, r...
10/13-14 from 1-5pm SGT
Coming to you from a safe, physical distance, Abbott 2020 world oncology summit. Covering diverse and timely topics in cancer education, from updates in cancer emerging new diagnostics resea...
OCT 11, 2017
| 6:00 AM PDT
The 5th Annual Event in the Cancer Research & Oncology Week Virtual Event Series is now On-Demand!...
OCT 05, 2016
| 6:00 AM PDT
The 4th Annual Event in the Cancer Research & Oncology Week Virtual Event Series is now On Demand! This premier cancer research conference makes it easier and more cost-effective for the...
SEP 30, 2015
| 6:00 AM PDT
Welcome to Labroots 3rd Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...
MAY 28, 2014
| 6:00 AM PDT
This year will be our 5th Annual Event in the Clinical Diagnostics & Research Virtual Event Series. Attendees can earn free CME and CE Credits....
AUG 21, 2013
| 6:00 AM PDT
C.E. CREDITS
The theme of this conference is a range of genetics and genomics topics such as RNAi, Next-generation sequencing, Cancer research, Sequencing, Genome-wide association studies GWAS, Epigenetic...